Dr. Lorraine Nolan:

I concur with everything Mr. Quinn said. We need to clarify it on the basis of paediatric total parenteral nutrition products manufactured in Ireland. Mr. Quinn is correct. These are high risk products and vulnerable patient groups. Everything we have done has the highest priority. There is complexity and there are multiple suppliers.